The European Tribune is a forum for thoughtful dialogue of European and international issues. You are invited to post comments and your own articles.
Please REGISTER to post.
If I interpret the language correctly (I am a native English speaker, but DoH seems to write in something else) the most obvious potential for devilry is in the tariff-setting. If it's slightly wrong, some activities will be more profitable than others. In a PbR system, who's going to want to do the less profitable types of clinical work?
So if you have the 'wrong' type of illness, tough luck!
No idea if there's a mechanism to correct for this. NuLab's managerial abilities in other fields suggests not.
by gmoke - Apr 22 5 comments
by Frank Schnittger - Apr 23 3 comments
by gmoke - Apr 30
by Oui - May 15
by Oui - May 14
by Oui - May 135 comments
by gmoke - May 13
by Oui - May 1321 comments
by Oui - May 12
by Oui - May 119 comments
by Oui - May 11
by Oui - May 109 comments
by Oui - May 10
by Oui - May 921 comments
by Oui - May 9
by Oui - May 81 comment
by Oui - May 73 comments
by Oui - May 7
by Oui - May 63 comments
by Oui - May 61 comment
by Oui - May 5
by Oui - May 58 comments